Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

93.70 

0.93 1.0%

as of Nov 16 '18

52 Week Range:

76.41 100.15


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation product; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; hardware instruments and mesh fixation device; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, colorectal surgeons, urogynecologists, interventional radiologists, and ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and therapy management software. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Apr '08 Apr '09 Apr '10 Apr '11 Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18
Equity (BVPS) 10.25
11.48
13.33
14.35
16.50
17.55
19.37
14.19
36.32
36.06
37.09
growth rate 12.0% 16.1% 7.7% 15.0% 6.4% 10.4% -26.7% 156.0% -0.7% 2.9%
Earnings BIT 2,890.00
2,590.00
3,970.00
3,720.00
4,150.00
4,250.00
4,084.00
4,972.00
5,719.00
6,095.00
6,855.00
growth rate -10.4% 53.3% -6.3% 11.6% 2.4% -3.9% 21.7% 15.0% 6.6% 12.5%
Avg.PE 24.94
16.58
15.65
14.58
11.86
13.85
19.49
31.19
35.09
30.44
38.03
growth rate -33.5% -5.6% -6.8% -18.7% 16.8% 40.7% 60.0% 12.5% -13.3% 24.9%
ROA 10.70
9.46
11.98
10.58
11.39
10.21
8.42
3.70
3.43
4.04
3.25
growth rate -11.6% 26.6% -11.7% 7.7% -10.4% -17.5% -56.1% -7.3% 17.8% -19.6%
ROE 19.82
17.79
22.55
20.24
21.87
19.38
16.08
7.36
6.72
7.87
6.15
growth rate -10.2% 26.8% -10.2% 8.1% -11.4% -17.0% -54.2% -8.7% 17.1% -21.9%
ROIC 12.55
11.35
14.86
13.32
13.97
12.63
10.45
4.79
5.00
5.59
4.67
growth rate -9.6% 30.9% -10.4% 4.9% -9.6% -17.3% -54.2% 4.4% 11.8% -16.5%
Cur. Ratio 2.07
2.37
1.92
1.93
1.62
4.57
3.82
3.36
3.29
1.75
2.28
growth rate 14.5% -19.0% 0.5% -16.1% 182.1% -16.4% -12.0% -2.1% -46.8% 30.3%
Quick Ratio 1.41
1.52
1.39
1.33
1.09
3.94
3.38
2.83
2.64
1.36
1.71
growth rate 7.8% -8.6% -4.3% -18.1% 261.5% -14.2% -16.3% -6.7% -48.5% 25.7%
Leverage 1.92
1.84
1.92
1.91
1.93
1.87
1.95
2.00
1.92
1.98
1.80
growth rate -4.2% 4.4% -0.5% 1.1% -3.1% 4.3% 2.6% -4.0% 3.1% -9.1%
Balance Sheet Apr '08 Apr '09 Apr '10 Apr '11 Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18
Acct.Receivable 3,287.00
3,123.00
3,335.00
3,822.00
4,511.00
4,266.00
4,547.00
5,112.00
5,562.00
5,591.00
5,987.00
growth rate -5.0% 6.8% 14.6% 18.0% -5.4% 6.6% 12.4% 8.8% 0.5% 7.1%
Acct.Payable 2,653.00
681.00
3,946.00
1,610.00
1,709.00
1,555.00
1,628.00
growth rate -74.3% 479.4% -59.2% 6.2% -9.0% 4.7%
Cur.Assets 7,322.00
7,452.00
9,839.00
9,117.00
16,336.00
17,852.00
21,210.00
30,844.00
23,600.00
24,873.00
22,980.00
growth rate 1.8% 32.0% -7.3% 79.2% 9.3% 18.8% 45.4% -23.5% 5.4% -7.6%
Total Assets 22,198.00
23,588.00
28,090.00
30,424.00
32,818.00
34,900.00
37,943.00
106,685.00
99,644.00
99,857.00
91,393.00
growth rate 6.3% 19.1% 8.3% 7.9% 6.3% 8.7% 181.2% -6.6% 0.2% -8.5%
Cash 1,613.00
1,271.00
1,400.00
1,382.00
1,172.00
919.00
1,403.00
4,843.00
2,876.00
4,967.00
3,669.00
growth rate -21.2% 10.2% -1.3% -15.2% -21.6% 52.7% 245.2% -40.6% 72.7% -26.1%
Inventory 1,280.00
1,426.00
1,481.00
1,695.00
1,800.00
1,712.00
1,725.00
3,463.00
3,473.00
3,338.00
3,579.00
growth rate 11.4% 3.9% 14.5% 6.2% -4.9% 0.8% 100.8% 0.3% -3.9% 7.2%
Cur.Liabilities 3,535.00
3,147.00
5,121.00
4,714.00
5,927.00
3,950.00
5,559.00
9,173.00
7,165.00
14,264.00
10,084.00
growth rate -11.0% 62.7% -8.0% 25.7% -33.4% 40.7% 65.0% -21.9% 99.1% -29.3%
Liabilities 10,662.00
10,406.00
13,461.00
14,456.00
15,705.00
16,229.00
18,500.00
53,455.00
47,581.00
49,527.00
40,571.00
growth rate -2.4% 29.4% 7.4% 8.6% 3.3% 14.0% 189.0% -11.0% 4.1% -18.1%
LT Debt 5,802.00
6,253.00
6,944.00
8,112.00
7,359.00
9,607.00
10,315.00
33,694.00
30,135.00
25,909.00
23,698.00
growth rate 7.8% 11.1% 16.8% -9.3% 30.6% 7.4% 226.7% -10.6% -14.0% -8.5%
Equity 11,536.00
13,182.00
14,629.00
15,968.00
17,113.00
18,671.00
19,443.00
53,230.00
52,063.00
50,208.00
50,720.00
growth rate 14.3% 11.0% 9.2% 7.2% 9.1% 4.1% 173.8% -2.2% -3.6% 1.0%
Common Shares 1,142.00
1,126.00
1,109.00
1,082.00
1,060.00
1,028.00
1,014.00
1,109.00
1,426.00
1,391.00
1,368.00
growth rate -1.4% -1.5% -2.4% -2.0% -3.0% -1.4% 9.4% 28.6% -2.5% -1.7%
Cash Flow Statement Apr '08 Apr '09 Apr '10 Apr '11 Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18
Capital Expenditures 606.00
498.00
573.00
501.00
484.00
457.00
396.00
571.00
1,046.00
1,254.00
1,068.00
growth rate -17.8% 15.1% -12.6% -3.4% -5.6% -13.4% 44.2% 83.2% 19.9% -14.8%
Cash Dividends 565.00
843.00
907.00
969.00
1,021.00
1,055.00
1,116.00
1,337.00
2,139.00
2,376.00
2,494.00
growth rate 49.2% 7.6% 6.8% 5.4% 3.3% 5.8% 19.8% 60.0% 11.1% 5.0%
Cash From OA 3,489.00
3,878.00
4,131.00
3,741.00
4,470.00
4,942.00
4,959.00
4,902.00
5,218.00
6,880.00
4,684.00
growth rate 11.2% 6.5% -9.4% 19.5% 10.6% 0.3% -1.2% 6.5% 31.9% -31.9%
FCF per Share 2.52
2.86
3.15
3.27
3.75
4.14
4.36
3.89
3.39
3.68
3.14
growth rate 13.5% 10.1% 3.8% 14.7% 10.4% 5.3% -10.8% -12.9% 8.6% -14.7%
Sale Purchase of Stock -1,344.00
-980.00
-1,246.00
649.00
491.00
428.00
403.00
growth rate 0.0% 0.0% 100.0% -24.4% -12.8% -5.8%
FCF 2,883.00
3,215.00
3,496.00
3,193.00
3,971.00
4,426.00
4,563.00
4,331.00
4,172.00
5,626.00
3,616.00
growth rate 11.5% 8.7% -8.7% 24.4% 11.5% 3.1% -5.1% -3.7% 34.9% -35.7%
Income Statement Apr '08 Apr '09 Apr '10 Apr '11 Apr '12 Apr '13 Apr '14 Apr '15 Apr '16 Apr '17 Apr '18
Sales 13,515.00
14,599.00
15,817.00
15,508.00
16,184.00
16,569.00
17,005.00
20,261.00
28,833.00
29,710.00
29,953.00
growth rate 8.0% 8.3% -2.0% 4.4% 2.4% 2.6% 19.2% 42.3% 3.0% 0.8%
Op.Income 2,740.00
2,440.00
3,969.00
3,664.00
3,415.00
3,467.00
3,813.00
4,972.00
5,719.00
6,095.00
6,855.00
growth rate -11.0% 62.7% -7.7% -6.8% 1.5% 10.0% 30.4% 15.0% 6.6% 12.5%
IBT 2,740.00
2,440.00
3,969.00
3,664.00
4,145.00
4,251.00
3,705.00
3,486.00
4,336.00
4,602.00
5,675.00
growth rate -11.0% 62.7% -7.7% 13.1% 2.6% -12.8% -5.9% 24.4% 6.1% 23.3%
Net Income 2,138.00
2,070.00
3,099.00
3,096.00
3,415.00
3,467.00
3,065.00
2,675.00
3,538.00
4,028.00
3,104.00
growth rate -3.2% 49.7% -0.1% 10.3% 1.5% -11.6% -12.7% 32.3% 13.9% -22.9%
EPS 1.95
1.84
2.79
2.86
3.41
3.37
3.02
2.41
2.48
2.89
2.27
growth rate -5.6% 51.6% 2.5% 19.2% -1.2% -10.4% -20.2% 2.9% 16.5% -21.5%
Gross Profit 10,069.00
11,081.00
12,005.00
11,808.00
12,295.00
12,474.00
12,672.00
14,590.00
19,926.00
20,477.00
20,983.00
growth rate 10.1% 8.3% -1.6% 4.1% 1.5% 1.6% 15.1% 36.6% 2.8% 2.5%
R&D 1,355.00
1,460.00
1,472.00
1,490.00
1,557.00
1,477.00
1,640.00
2,224.00
2,193.00
2,253.00
growth rate 7.8% 0.8% 1.2% 4.5% -5.1% 11.0% 35.6% -1.4% 2.7%

Quarterly Statements

Item Name Jul '17 Oct '17 Jan '18 Apr '18 Jul '18
Earnings BIT 1,521.00
1,471.00
1,794.00
2,016.00
1,434.00
growth rate -3.3% 22.0% 12.4% -28.9%
Balance Sheet Jul '17 Oct '17 Jan '18 Apr '18 Jul '18
Acct.Receivable 5,784.00
5,752.00
5,775.00
5,987.00
5,674.00
growth rate -0.6% 0.4% 3.7% -5.2%
Acct.Payable 1,759.00
1,718.00
1,809.00
1,628.00
1,789.00
growth rate -2.3% 5.3% -10.0% 9.9%
Cur.Assets 24,779.00
25,162.00
26,607.00
22,980.00
22,460.00
growth rate 1.6% 5.7% -13.6% -2.3%
Total Assets 100,250.00
94,458.00
95,800.00
91,393.00
89,721.00
growth rate -5.8% 1.4% -4.6% -1.8%
Cash 4,691.00
5,529.00
6,358.00
3,669.00
4,380.00
growth rate 17.9% 15.0% -42.3% 19.4%
Inventory 3,538.00
3,638.00
3,751.00
3,579.00
3,681.00
growth rate 2.8% 3.1% -4.6% 2.9%
Cur.Liabilities 15,148.00
10,496.00
10,933.00
10,084.00
9,112.00
growth rate -30.7% 4.2% -7.8% -9.6%
Liabilities 49,463.00
42,880.00
45,460.00
40,571.00
39,392.00
growth rate -13.3% 6.0% -10.8% -2.9%
LT Debt 25,940.00
25,927.00
25,909.00
23,698.00
23,675.00
growth rate -0.1% -0.1% -8.5% -0.1%
Equity 50,672.00
51,469.00
50,234.00
50,720.00
50,224.00
growth rate 1.6% -2.4% 1.0% -1.0%
Common Shares
growth rate
Cash Flow Statement Jul '17 Oct '17 Jan '18 Apr '18 Jul '18
Capital Expenditures 278.00
246.00
252.00
292.00
291.00
growth rate -11.5% 2.4% 15.9% -0.3%
Cash Dividends 625.00
622.00
623.00
624.00
677.00
growth rate -0.5% 0.2% 0.2% 8.5%
Cash From OA 737.00
907.00
2,002.00
1,038.00
1,702.00
growth rate 23.1% 120.7% -48.2% 64.0%
Sale Purchase of Stock 143.00
87.00
103.00
70.00
growth rate -39.2% 18.4% -32.0%
FCF 459.00
661.00
1,750.00
746.00
1,411.00
growth rate 44.0% 164.8% -57.4% 89.1%
Income Statement Jul '17 Oct '17 Jan '18 Apr '18 Jul '18
Sales 7,390.00
7,050.00
7,369.00
8,144.00
7,384.00
growth rate -4.6% 4.5% 10.5% -9.3%
Op.Income 1,521.00
1,471.00
1,794.00
2,016.00
1,434.00
growth rate -3.3% 22.0% 12.4% -28.9%
IBT 1,195.00
1,728.00
1,027.00
1,725.00
1,180.00
growth rate 44.6% -40.6% 68.0% -31.6%
Net Income 1,016.00
2,017.00
-1,389.00
1,460.00
1,075.00
growth rate 98.5% -100.0% 100.0% -26.4%
EPS
growth rate
Gross Profit 5,055.00
4,965.00
5,195.00
5,768.00
5,195.00
growth rate -1.8% 4.6% 11.0% -9.9%
R&D 548.00
555.00
558.00
592.00
585.00
growth rate 1.3% 0.5% 6.1% -1.2%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (20.10)

YOY Growth Grade:

D (33.87)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 39.97 40.41 16.70
EPS / Growth 4.8% 2.32 6.9%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 13.4%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 4.8% 8.4% 8.4%
Future PE 9.68 24.48 24.48
Future EPS 3.72 5.19 5.19
Value Price
MOS %
8.90
-90.5%
31.41
-66.5%
31.41
-66.5%
MOS Price 4.45 15.71 15.71
IRT 22.27 17.59 17.59

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.